Corporate Responsibility Report

The report describes Genmab's 2021 CSR highlights, including its first qualitative and quantitative TCFD disclosure and Scope 1 and 2 accounting under the GHG Protocol. It reports 1,212 year-end FTEs, 58% overall female representation, and 50% female representation on the Board. The company also launched global employee giving programs and expanded environmental initiatives including renewable electricity, recycling, and biodiversity measures.